Death associated with rifampin and pyrazinamide 2-month treatment of latent mycobacterium tuberculosis

Chest

Volumn 121, Issue 5, 2002, Pages 1710-1712

  Medinger, Ann ^a  

^a NONE   (United States)

Author keywords

Drug toxicity; Latent tuberculosis treatment; Mycobacterium tuberculosis; Pyrazinamide; Rifampin

Indexed keywords

PYRAZINAMIDE; RIFAMPICIN;

AGED; ARTICLE; CASE REPORT; DEATH; DRUG SAFETY; HUMAN; LIVER FAILURE; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

EID: 0036246860     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.5.1710     Document Type: Article

References (6)

1. Targeted tuberculin testing and treatment of latent tuberculosis infection
2. Fatal and severe hepatitis associated with rifampin, and pyrazinamide for the treatment of latent tuberculosis infection: New York, and Georgia, 2000
3. Severe hepatotoxicity of tuberculostatic agents: Increase in incidence
4. Preventive therapy for tuberculosis
5. Tuberculosis in the elderly
6. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: An international randomized trial